Adenocarcinoma, Scirrhous
1 clinical trials · Condition
◉ Watch Adenocarcinoma, Scirrhous
| Record | Firm | Date |
|---|---|---|
| A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients (NCT01576380) | Novartis Pharmaceuticals | 2012-06-01 |
Track Adenocarcinoma, Scirrhous automatically
Every clearance here is in the API, with alerts when new ones post.